Evidence map›Paper›PMID 26919336›Full record

ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2016

Thrombin inhibition during PCI in heart failure patients.

Yusuf Bader, Carey Kimmelstiel

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yusuf BaderCardiac Catheterization Laboratory, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts.
Carey KimmelstielCardiac Catheterization Laboratory, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts.
Tufts Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this retrospective analysis, CHF patients undergoing PCI had a decrease in mortality, bleeding, and transfusion as well as decreased length of stay and hospital cost when bivalirudin was used when compared to heparin. This study suggests bivalirudin may be the preferred anticoagulant for patients with CHF undergoing PCI. Confirmation of these data might entail analysis of patient-level, pooled data from randomized controlled trials comparing bivalirudin to heparin in PCI patients with pre-existing CHF.

Indexed as

ThrombinAngioplasty, Balloon, CoronaryAnticoagulantsAntithrombinsHeart FailureHemorrhageHeparinHumansPlatelet Glycoprotein GPIIb-IIIa ComplexRecombinant ProteinsRetrospective StudiesTreatment OutcomeAnticoagulantsAntithrombinsHeparinPlatelet Glycoprotein GPIIb-IIIa ComplexRecombinant ProteinsThrombin

Identifiers

PMID26919336
OpenAlexW2291917590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.